SCHEMBL18360203

SCHEMBL18360203

CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)OCCNC(=O)OC(C)(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 3/20 0.56
CTSL P07711 2/20 0.56
CTSS P25774 2/20 0.56
CTSB P07858 1/20 0.56
CAPN1 P07384 1/20 0.52
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
NPSR1 Q6W5P4 2/20 0.47
MAPT P10636 1/20 0.47
TDP1 Q9NUW8 2/20 0.45
POLB P06746 1/20 0.45
ATM Q13315 1/20 0.45
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
CA7 P43166 1/20 0.44
GAA P10253 1/20 0.43
RECQL P46063 1/20 0.43
IDO1 P14902 1/20 0.42
AAK1 Q2M2I8 1/20 0.42
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12214541 0.85 CTSK (0.55) CTSKCTSLCTSSCTSBCAPN1
SCHEMBL18354713 0.84 MEN1 (0.46) CTSKCTSLCTSSCTSBCAPN1
SCHEMBL21675512 0.83 CTSK (0.61) CTSKCTSLCTSSCTSBCAPN1
SCHEMBL13519734 0.83 CTSK (0.52) CTSKCTSLCTSSCTSBCAPN1
SCHEMBL21561546 0.82 KMT2A (0.47) CTSKCTSLCTSSCTSBMEN1
SCHEMBL15374288 0.82 CYP1A2 (0.59) CTSKCTSLCTSSCTSBCAPN1
SCHEMBL9596442 0.82 CYP1A2 (0.59) CTSKCTSLCTSSCTSBCAPN1
SCHEMBL15107084 0.82 CYP1A2 (0.59) CTSKCTSLCTSSCTSBCAPN1
SCHEMBL15304537 0.82 MEN1 (0.52) CTSKCTSSMEN1KMT2ANPSR1
SCHEMBL27808938 0.82 CTSK (0.51) CTSKCTSLCTSSCTSBCAPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919840-B2 Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials SEIKAGAKU CORPORATION (JP) 2021-02-16 US disclosed
EP-3101064-B1 DIAMINE CROSSLINKING AGENT, ACIDIC POLYSACCHARIDE CROSSLINKED BODY, AND MEDICAL MATERIAL SEIKAGAKU KOGYO CO LTD (JP) 2020-07-15 EP disclosed
US-20190345312-A1 DIAMINE CROSSLINKING AGENTS, CROSSLINKED ACIDIC POLYSACCHARIDES AND MEDICAL MATERIALS SEIKAGAKU CORPORATION (JP) 2019-11-14 US disclosed
US-10294195-B2 Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials SEIKAGAKU CORPORATION (JP) 2019-05-21 US disclosed
US-20170001948-A1 DIAMINE CROSSLINKING AGENTS, CROSSLINKED ACIDIC POLYSACCHARIDES AND MEDICAL MATERIALS SEIKAGAKU CORPORATION (JP) 2017-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10294195-B2 Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials SAT1, ACMSD, ADM2 CTSK 4211/4885CTSL 4159/4885CTSS 4147/4885
US-20170001948-A1 DIAMINE CROSSLINKING AGENTS, CROSSLINKED ACIDIC POLYSACCHARIDES AND MEDICAL MATERIALS SAT1, ACMSD, ADM2 CTSK 4211/4885CTSL 4159/4885CTSS 4147/4885
US-10919840-B2 Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials SAT1, ACMSD, ADM2 CTSK 4211/4885CTSL 4159/4885CTSS 4147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.